Hui-Feng Zhu (Huifeng Zhu)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Neoadjuvant Chemotherapy

Angiotensin Converting Enzyme

Cerebral Ischemia

Neural Stem Cells

Top Venues

Infection and drug resistance

Drug design, development and therapy

Molecules (Basel, Switzerland)

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Jinghui Wang, Yuhua Zhang, Meifeng Zhang, Si Sun, Yang Zhong, Lei Han, Yitong Xu, Dong Wan, Junhui Zhang, Hui-Feng Zhu
Feasibility of Catalpol Intranasal Administration and Its Protective Effect on Acute Cerebral Ischemia in Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms. Drug design, development and therapy 16 (2022)
Jinghui Wang, Meifeng Zhang, Si Sun, Guoran Wan, Dong Wan, Shan Feng, Hui-Feng Zhu
Network Pharmacology-Based Prediction of Catalpol and Mechanisms against Stroke. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Siyu Luo, Hui-Feng Zhu, Junhui Zhang, Dong Wan
The Pivotal Role of Microbiota in Modulating the Neuronal-Glial-Epithelial Unit. Infection and drug resistance 14 (2021)
Wei Tang, Hui-Feng Zhu, Yanmei Feng, Rui Guo, Dong Wan
The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier. Infection and drug resistance 13 (2020)
Hui-Feng Zhu, Yali Shao, Lei Qin, Jing-Huan Wang, Shan Feng, Yun-Bin Jiang, Dong Wan
Catalpol Enhances Neurogenesis And Inhibits Apoptosis Of New Neurons Via BDNF, But Not The BDNF/Trkb Pathway. Drug design, development and therapy 13 (2019)
Shan Feng, Li Zou, Hongjin Wang, Ran He, Ke Liu, Hui-Feng Zhu
RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability. Molecules (Basel, Switzerland) 23 (9) (2018)